STAGED ACQUISITION OF UNIVERSITY
SPIN-OUT PHAGENESIS BY NESTLÉ
HEALTH SCIENCE WILL BENEFIT
PATIENTS WITH DYSPHAGIA
Nestlé Health Science (NHSc) and Phagenesis
announced in September that NHSc is entering
into a staged, milestone-based acquisition of
Phagenesis, a medical device company that has
developed a new treatment for dysphagia.
UMIP HIGHLIGHTS
